Cargando…

Genetic association study of synphilin-1 in idiopathic Parkinson's disease

BACKGROUND: Post-mortem Lewy body and Lewy neuritic inclusions are a defining feature of Parkinson's disease (PD) and dementia with Lewy bodies (DLB). With the discovery of missense and multiplication mutations in the alpha-synuclein gene (SNCA) in familial parkinsonism, Lewy inclusions were fo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Myhre, Ronny, Klungland, Helge, Farrer, Matthew J, Aasly, Jan O
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2008
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2329608/ https://www.ncbi.nlm.nih.gov/pubmed/18366718 http://dx.doi.org/10.1186/1471-2350-9-19

Ejemplares similares

Splicing variants of porcine synphilin-1()
por: Larsen, Knud, et al.
Publicado: (2015)

A Case of Parkinson's Disease with No Lewy Body Pathology due to a Homozygous Exon Deletion in Parkin
por: Johansen, Krisztina Kunszt, et al.
Publicado: (2018)

Behavioral Characterization of the Hyperphagia Synphilin-1 Overexpressing Mice
por: Li, Xueping, et al.
Publicado: (2014)

CCK Response Deficiency in Synphilin-1 Transgenic Mice
por: Smith, Wanli W., et al.
Publicado: (2015)

Synphilin-1 Interacts with AMPK and Increases AMPK Phosphorylation
por: Li, Tianxia, et al.
Publicado: (2020)

The Guanine Nucleotide Exchange Factor Kalirin-7 Is a Novel Synphilin-1 Interacting Protein and Modifies Synphilin-1 Aggregate Transport and Formation
por: Tsai, Yu-Chun, et al.
Publicado: (2012)

Long-Term Outcomes of Genetic Parkinson’s Disease
por: Aasly, Jan O.
Publicado: (2020)

Exploring cancer in LRRK2 mutation carriers and idiopathic Parkinson's disease
por: Warø, Bjørg Johanne, et al.
Publicado: (2017)

Synphilin-1 Binds ATP and Regulates Intracellular Energy Status
por: Li, Tianxia, et al.
Publicado: (2014)

Hypermethylation of Synphilin-1, Alpha-Synuclein-Interacting Protein (SNCAIP) Gene in the Cerebral Cortex of Patients with Sporadic Parkinson’s Disease
por: Dashtipour, Khashayar, et al.
Publicado: (2017)

Significance of the parkin and PINK1 gene in Jordanian families with incidences of young-onset and juvenile parkinsonism
por: Myhre, Ronny, et al.
Publicado: (2008)

GBA1 in Parkinson’s disease: variant detection and pathogenicity scoring matters
por: Gabbert, Carolin, et al.
Publicado: (2023)

Nicotine suppresses Parkinson’s disease like phenotypes induced by Synphilin-1 overexpression in Drosophila melanogaster by increasing tyrosine hydroxylase and dopamine levels
por: Carvajal-Oliveros, Angel, et al.
Publicado: (2021)

A novel obesity model: Synphilin-1 induced hyperphagia and obesity in mice
por: Li, Xueping, et al.
Publicado: (2011)

Writers Are Common among Parkinson's Disease Patients: A Longitudinal Study
por: Aasly, Anna, et al.
Publicado: (2021)

Yeasts as Complementary Model Systems for the Study of the Pathological Repercussions of Enhanced Synphilin-1 Glycation and Oxidation
por: Seynnaeve, David, et al.
Publicado: (2021)

Genetics and genomics of Parkinson’s disease
por: Lin, Michelle K, et al.
Publicado: (2014)

Clinical and Imaging Markers of Prodromal Parkinson's Disease
por: Hustad, Eldbjørg, et al.
Publicado: (2020)

Parkinsonian phenotypes induced by Synphilin-1 expression are differentially contributed by serotonergic and dopaminergic circuits and suppressed by nicotine treatment
por: Carvajal-Oliveros, Angel, et al.
Publicado: (2023)

A genome-wide imaging-based screening to identify genes involved in synphilin-1 inclusion formation in Saccharomyces cerevisiae
por: Zhao, Lei, et al.
Publicado: (2016)

The accuracy of the clinical diagnosis of Parkinson disease. The HUNT study
por: Hustad, Eldbjørg, et al.
Publicado: (2018)

Increased Mortality in Young-Onset Parkinson’s Disease
por: Hustad, Eldbjørg, et al.
Publicado: (2021)

Synphilin-1 Enhances α-Synuclein Aggregation in Yeast and Contributes to Cellular Stress and Cell Death in a Sir2-Dependent Manner
por: Büttner, Sabrina, et al.
Publicado: (2010)

The influence of preconditioning with low dose of LPS on paraquat-induced neurotoxicity, microglia activation and expression of α-synuclein and synphilin-1 in the dopaminergic system
por: Kuter, Katarzyna Z., et al.
Publicado: (2021)

What Have We Learned from Cerebrospinal Fluid Studies about Biomarkers for Detecting LRRK2 Parkinson’s Disease Patients and Healthy Subjects with Parkinson’s-Associated LRRK2 Mutations?
por: Loeffler, David A., et al.
Publicado: (2019)

Genetic Influences on Cognition in Idiopathic Parkinson's Disease
por: Amer, Hanan, et al.
Publicado: (2018)

Combining clinical and biofluid markers for early Parkinson's disease detection
por: Yu, Zhenwei, et al.
Publicado: (2017)

Dopamine Transporter Genetic Variants and Pesticides in Parkinson’s Disease
por: Ritz, Beate R., et al.
Publicado: (2009)

Disease-Associated α-Synuclein Aggregates as Biomarkers of Parkinson Disease Clinical Stage
por: Majbour, Nour, et al.
Publicado: (2022)

In Vivo Mitochondrial Function in Idiopathic and Genetic Parkinson’s Disease
por: Dossi, Gabriele, et al.
Publicado: (2019)

Editorial: Celebrating the Diversity of Genetic Research to Dissect the Pathogenesis of Parkinson's Disease
por: Farrer, Matthew J., et al.
Publicado: (2021)

Increased Oxidative Stress Markers in Cerebrospinal Fluid from Healthy Subjects with Parkinson’s Disease-Associated LRRK2 Gene Mutations
por: Loeffler, David A., et al.
Publicado: (2017)

Metabolomic Profiling in LRRK2-Related Parkinson's Disease
por: Johansen, Krisztina K., et al.
Publicado: (2009)

Bilateral Optic Neuritis Associated with the Use of Infliximab
por: Aasly, Jan O.
Publicado: (2011)

Prophylactic Allogeneic Hematopoietic Stem Cell Therapy for CSF1R ‐Related Leukoencephalopathy
por: Horn, Morten Andreas, et al.
Publicado: (2022)

Microtubule Destabilization Is Shared by Genetic and Idiopathic Parkinson’s Disease Patient Fibroblasts
por: Cartelli, Daniele, et al.
Publicado: (2012)

Premotor Gray Matter Volume is Associated with Clinical Findings in Idiopathic and Genetically Determined Parkinson’s Disease
por: Reetz, K, et al.
Publicado: (2008)

Inflammatory Diseases Among Norwegian LRRK2 Mutation Carriers. A 15-Years Follow-Up of a Cohort
por: Aasly, Jan O.
Publicado: (2021)

Changes to Intermediary Metabolites in Sporadic and LRRK2 Parkinson's Disease Demonstrated by Proton Magnetic Resonance Spectroscopy
por: Aasly, Jan O., et al.
Publicado: (2015)

Correction: Microtubule Destabilization Is Shared by Genetic and Idiopathic Parkinson’s Disease Patient Fibroblasts
por: Cartelli, Daniele, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_m85jtdv8qdg0o2ave1pnm2poil